BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Mast Cell Issues / mastitis |
📓
TLR2 Regulates Mast Cell IL-6 and IL-13 Production During Listeria monocytogenes Infection. Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 650779 Pub: 2021 Epub: 2021 Jun 14 Authors Soria-Castro R , Alfaro-Doblado ÁR , Rodríguez-López G , Campillo-Navarro M , Meneses-Preza YG , Galán-Salinas A , Alvarez-Jimenez V , Yam-Puc JC , Munguía-Fuentes R , Domínguez-Flores A , Estrada-Parra S , Pérez-Tapia SM , Chávez-Blanco AD , Chacón-Salinas R , Html Article Publication |
| Mast Cell Issues / mastitis |
📓
Acinetobacter baumannii LOS Regulate the Expression of Inflammatory Cytokine Genes and Proteins in Human Mast Cells. Pathogens (Basel, Switzerland) (Pathogens ) Vol: 10 Issue 3 Pages: Pub: 2021 Mar 3 Epub: 2021 Mar 3 Authors Kikuchi-Ueda T , Ubagai T , Kamoshida G , Nakano R , Nakano A , Ono Y , Html Article Publication |
| Mast Cell Issues / mastitis |
📓
Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression. Journal of ginseng research (J Ginseng Res ) Vol: 43 Issue 4 Pages: 635-644 Pub: 2019 Oct Epub: 2019 Mar 7 Authors Kim HI , Kim JK , Kim JY , Han MJ , Kim DH , Html Article Publication |
| Mast Cell Issues / mastitis |
📓
Live Staphylococcus aureus Induces Expression and Release of Vascular Endothelial Growth Factor in Terminally Differentiated Mouse Mast Cells. Frontiers in immunology (Front Immunol ) Vol: 7 Issue Pages: 247 Pub: 2016 Epub: 2016 Jun 23 Authors Johnzon CF , Rönnberg E , Guss B , Pejler G , Html Article Publication |
| Mast Cell Issues / mastitis |
📓
Reactivity of mast cells to Mycoplasma salivarium. Infection and immunity (Infect Immun ) Vol: 11 Issue 3 Pages: 598-600 Pub: 1975 Mar Epub: Authors Parkinson CF , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
